Exploring Barriers and Facilitators to Drug Launch Success
Summary: Developing new drugs is a lengthy, expensive, high-risk process. Even after launch, close to half of new drugs underperform compared to analyst expectations.To better understand the decisions and processes underlying these outcomes, Catalent conducted an exclusive survey of pharma industry professionals. Pharma execs identified the top success factors for new drugs, revealed specific issues that hurt new treatment performance, and suggested practical solutions for optimizing the drug development process.
This webinar will provide an exclusive first look at the survey data and will give you insights to help optimize your next drug’s performance in the real world.